Brind.

Omeros Corporation Discloses Insider Trading Filings with SEC

1 report, 1 independent Updated Sep 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Omeros Corporation disclosed insider trading filings with the U.S. Securities and Exchange Commission on September 22, 2026.

From themarketsdaily.com

Why it matters

Some supportBrind's analysis of the reports

The disclosure relates to Omeros Corporation's compliance with the regulatory oversight and filing requirements of the SEC.

From themarketsdaily.com

Who's involved

  • Omeros CorporationPublicly traded biopharmaceutical company subject to SEC oversight
  • SECU.S. regulatory body overseeing securities filings

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped